Whan In Pharm Co.,Ltd. (KRX:016580)

Market Cap	174.35B
Revenue (ttm)	259.60B
Net Income (ttm)	23.38B
Shares Out	15.27M
EPS (ttm)	1,531.45
PE Ratio	7.46
Forward PE	8.63
Dividend	300.00 (2.60%)
Ex-Dividend Date	Dec 27, 2024

Volume	12,736
Average Volume	12,966
Open	11,480
Previous Close	11,480
Day's Range	11,480 - 11,930
52-Week Range	11,250 - 15,900
Beta	0.17
RSI	40.01
Earnings Date	May 2, 2025

About Whan In Pharm

Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceuticals products in South Korea. The company offers anti-depressants, anti-psychotics, nootropics and anti-dementia, anti-epileptics, cardiovascular, gastrointestinal, antibiotics, antiviral agents, antihistamines, anti-inflammatory and analgesics, metabolic disorders, respiratory, central nervous system, other drug products. The company was founded in 1978 and is headquartered in Seoul, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1978
• Employees: 582
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 016580

Financial Performance

In 2024, Whan In Pharm's revenue was 259.60 billion, an increase of 12.68% compared to the previous year's 230.39 billion. Earnings were 23.38 billion, a decrease of -21.47%.